Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carbamate prodrug concept for hydroxamate HDAC inhibitors.

× No keyword cloud information.

16 in total

1. Targeting botulinum A cellular toxicity: a prodrug approach.

Authors: Peter Silhár; Lisa M Eubanks; Hajime Seki; Sabine Pellett; Sacha Javor; William H Tepp; Eric A Johnson; Kim D Janda
Journal: J Med Chem Date: 2013-10-15 Impact factor: 7.446

Review 2. Epigenetic drug discovery: breaking through the immune barrier.

Authors: David F Tough; Paul P Tak; Alexander Tarakhovsky; Rab K Prinjha
Journal: Nat Rev Drug Discov Date: 2016-10-21 Impact factor: 84.694

Review 3. Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11.

Authors: David F Tough; Huw D Lewis; Inmaculada Rioja; Matthew J Lindon; Rab K Prinjha
Journal: Br J Pharmacol Date: 2014-11 Impact factor: 8.739

4. H₂O₂/Peroxynitrite-Activated Hydroxamic Acid HDAC Inhibitor Prodrugs Show Antileukemic Activities against AML Cells.

Authors: Yi Liao; Liping Xu; Siyu Ou; Holly Edwards; Daniel Luedtke; Yubin Ge; Zhihui Qin
Journal: ACS Med Chem Lett Date: 2018-06-13 Impact factor: 4.345

5. Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain.

Authors: Hajime Seki; Sabine Pellett; Peter Silhár; G Neil Stowe; Beatriz Blanco; Matthew A Lardy; Eric A Johnson; Kim D Janda
Journal: Bioorg Med Chem Date: 2013-12-08 Impact factor: 3.641

6. Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors.

Authors: Shilong Zheng; Shanchun Guo; Qiu Zhong; Changde Zhang; Jiawang Liu; Lin Yang; Qiang Zhang; Guangdi Wang
Journal: ACS Med Chem Lett Date: 2018-01-08 Impact factor: 4.345

7. Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain.

Authors: Rana Rais; Jan Vávra; Tomáš Tichý; Ranjeet P Dash; Alexandra J Gadiano; Lukáš Tenora; Lenka Monincová; Cyril Bařinka; Jesse Alt; Sarah C Zimmermann; C Ethan Slusher; Ying Wu; Krystyna Wozniak; Pavel Majer; Takashi Tsukamoto; Barbara S Slusher
Journal: J Med Chem Date: 2017-09-18 Impact factor: 8.039

Carbamate prodrug concept for hydroxamate HDAC inhibitors.